Results 241 to 250 of about 703,662 (260)

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook, William D Figg
exaly  

Improving target assessment in biomedical research: the GOT-IT recommendations

Nature Reviews Drug Discovery, 2020
Christoph H Emmerich, Martine C J Hofmann, Björn Gerlach   +2 more
exaly  

Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application

Nature Reviews Drug Discovery, 2010
Aimee L Jackson
exaly  

Target classification

2013
openaire   +1 more source

Target classification

2001
openaire   +1 more source

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Therapeutic strategies to target RAS-mutant cancers

Nature Reviews Clinical Oncology, 2018
Ryan B Corcoran
exaly  

Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification

Signal Transduction and Targeted Therapy, 2020
Xiao Chen, Bo Zhu, Zhen Liang
exaly  

The drug–target residence time model: a 10-year retrospective

Nature Reviews Drug Discovery, 2015
Robert A Copeland
exaly  

Protein kinase C, an elusive therapeutic target?

Nature Reviews Drug Discovery, 2012
Daria Mochly-Rosen
exaly